Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder
← Find more feeds

roche.com

Investor Update

Get the latest updates from Investor Update directly as they happen.

Follow now 275 followers

Latest posts

Last updated 1 day ago

Invitation to Roche’s virtual Neuroscience Update IR Event

1 day ago

Roche to present new key clinical and real-world data at ECTRIMS-ACTRIMS 2023 showcasing strength of long-term outcomes in MS and NMOSD

1 day ago

Invitation to Roche’s 3rd Quarter Sales 2023 Webinar

12 days ago

Roche and Alnylam report positive topline results from Phase 2 study KARDIA-1 of zilebesiran, an investigational RNAi therapeutic in development to treat hypertension in patients at high risk of cardiovascular disease

26 days ago

FDA accepts application for Roche’s crovalimab for the treatment of PNH, a rare life-threatening blood condition

27 days ago

Roche’s Alecensa delivers unprecedented Phase III results for people with ALK-positive early-stage lung cancer

about 1 month ago

Reminder: Invitation to Roche’s Pharma Day 2023

about 1 month ago

Roche’s Tecentriq becomes the first subcutaneous anti-PD-(L)1 cancer immunotherapy available to patients in Great Britain, reducing treatment time to just minutes

about 1 month ago

European Commission approves Roche’s Evrysdi for babies under two months old with spinal muscular atrophy (SMA)

about 1 month ago

Reminder: Invitation to Roche’s Pharma Day 2023

about 1 month ago

[Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on Phase III Skyscraper-01 study in PD-L1-high metastatic non-small cell lung cancer

about 1 month ago

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong growth in both divisions’ base business; Group sales and profit reflect declining demand for COVID-19 products

2 months ago

Sign up to continue

Try Feeder for free

Everything you care about in one place

Try Feeder now